BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6141949)

  • 1. Vascular effects of apomorphine and related compounds in the perfused rat kidney.
    Schmidt M; Imbs JL; Neumeyer JL; Giesen EM; Schwartz J
    Eur J Pharmacol; 1984 Jan; 97(1-2):75-85. PubMed ID: 6141949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasodilator effects of dopaminomimetics in the perfused rat kidney.
    Schmidt M; Imbs JL; Giesen EM; Schwartz J
    Eur J Pharmacol; 1982 Oct; 84(1-2):61-70. PubMed ID: 6183130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of SK&F 82526 and SK&F 83742 on the renal vascular dopamine receptor.
    Schmidt M; Imbs JL; Giesen-Crouse EM; Schwartz J
    J Pharmacol; 1985; 16(1):15-22. PubMed ID: 2582206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacologic characteristics of renal dopaminergic receptors: therapeutic perspectives].
    Imbs JL; Schmidt M; Schwartz J
    J Pharmacol; 1983; 14 Suppl 3():5-27. PubMed ID: 6368999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of renal vascular dopamine receptors.
    Schmidt M; Imbs JL
    J Cardiovasc Pharmacol; 1980; 2(5):595-605. PubMed ID: 6157952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aporphines. 16. Action of aporphine alkaloids on locomotor activity in rats with 6-hydroxydopamine lesions of the nucleus accumbens.
    Kelly PH; Miller RJ; Neumeyer JL
    Eur J Pharmacol; 1976 Jan; 35(1):85-92. PubMed ID: 1253829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Do renal vascular D2 receptors exist?].
    Barthelmebs M; Krieger JP; Grima M; Imbs JL
    Arch Mal Coeur Vaiss; 1991 Aug; 84(8):1211-3. PubMed ID: 1953269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aporphines as antagonists of dopamine D-1 receptors.
    Schaus JM; Titus RD; Foreman MM; Mason NR; Truex LL
    J Med Chem; 1990 Feb; 33(2):600-7. PubMed ID: 2405158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aporphines. 15. Action of aporphine alkaloids on dopaminergic mechanisms in rat brain.
    Miller RJ; Kelly PH; Neumeyer JL
    Eur J Pharmacol; 1976 Jan; 35(1):77-83. PubMed ID: 943290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular effects of selective dopamine receptor agonists and antagonists in the rat kidney.
    Schmidt M; Krieger JP; Giesen-Crouse EM; Imbs JL
    Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):195-205. PubMed ID: 2954515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of (-)N-(chloroethyl)-norapomorphine on [3H]-apomorphine binding to striatal dopamine receptors.
    Goosey MW; Doggett NS
    Biochem Pharmacol; 1982 Nov; 31(22):3693-4. PubMed ID: 7181954
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of isomers of hydroxyaporphines on dopamine metabolism in rat brain regions.
    Baldessarini RJ; Marsh ER; Kula NS; Zong RS; Gao YG; Neumeyer JL
    Biochem Pharmacol; 1990 Aug; 40(3):417-23. PubMed ID: 2383279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
    Booth RG; Baldessarini RJ; Kula NS; Gao Y; Zong R; Neumeyer JL
    Mol Pharmacol; 1990 Jul; 38(1):92-101. PubMed ID: 1973525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the effects of apomorphine and bulbocapnine in relation to the proposed dopamine receptor.
    Patil PN; Burkman AM; Yamauchi D; Hetey S
    J Pharm Pharmacol; 1973 Mar; 25(3):221-8. PubMed ID: 4146322
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective action of two aporphines at alpha 1-adrenoceptors and potential-operated Ca2+ channels.
    Ivorra MD; ChuliĆ” S; Lugnier C; D'Ocon MP
    Eur J Pharmacol; 1993 Feb; 231(2):165-74. PubMed ID: 8384112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of vascular dopamine receptors in the gastric circulation of the rabbit.
    Reinsberg J; Kullmann R
    J Cardiovasc Pharmacol; 1986; 8(5):1067-73. PubMed ID: 2429081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular dopamine receptors: Demonstration and characterization by in vitro studies.
    Brodde OE
    Life Sci; 1982 Jul; 31(4):289-306. PubMed ID: 6292644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of dopamine receptors in the renal vasculature by isomers of flupenthixol and sulpiride.
    Schmidt M; Imbs JL; Giesen EM; Schwartz J
    J Cardiovasc Pharmacol; 1983; 5(1):86-9. PubMed ID: 6186865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of dihydropteridine reductase from human liver and rat striatal synaptosomes by apomorphine and its analogs.
    Shen RS; Smith RV; Davis PJ; Abell CW
    J Biol Chem; 1984 Jul; 259(14):8994-9000. PubMed ID: 6746636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Metabolism and vascular effects of gammaglutamyl L-dopa on the isolated kidney of the rat].
    Caillette A; Schmidt M; Ehrhardt JD; Imbs JL
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():179-82. PubMed ID: 3142404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.